Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 10/20 | 0.65 |
| ▸ | MAOA | P21397 | 6/20 | 0.61 |
| ▸ | RXRA | P19793 | 1/20 | 0.58 |
| ▸ | RXRB | P28702 | 1/20 | 0.58 |
| ▸ | RXRG | P48443 | 1/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | DHFR | P00374 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | GRM5 | P41594 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30399352 | 0.84 | MAOB (0.65) | MAOBMAOARXRARXRBRXRG | |
| SCHEMBL3423658 | 0.84 | MAOB (0.65) | MAOBMAOARXRARXRBRXRG | |
| SCHEMBL10169470 | 0.82 | MAOB (0.71) | MAOBMAOARXRARXRBRXRG | |
| SCHEMBL4412215 | 0.81 | MAOB (0.68) | MAOB | |
| SCHEMBL4417319 | 0.81 | MAOB (0.73) | MAOBMAOARXRARXRBRXRG | |
| SCHEMBL3624161 | 0.80 | MAOB (0.73) | MAOBMAOARXRARXRBRXRG | |
| SCHEMBL966917 | 0.80 | LMNA (0.60) | MAOBMAOA | |
| SCHEMBL11959143 | 0.80 | MAOB (0.72) | MAOBMAOARXRARXRBRXRG | |
| SCHEMBL21234325 | 0.79 | MAOB (0.67) | MAOBMAOARXRARXRBRXRG | |
| Methyl Alcohol SCHEMBL9626623 | 0.79 | RXRA (0.68) | MAOBMAOARXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1299354-B1 | FACTOR VIIA INHIBITORY (THIO)UREA DERIVATIVES, THEIR PREPARATION AND THEIR USE | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-07-22 | — | — | EP | claimed |
| EP-1299354-B1 | FACTOR VIIA INHIBITORY (THIO)UREA DERIVATIVES, THEIR PREPARATION AND THEIR USE | SANOFI AVENTIS DEUTSCHLAND (DE) | 2009-07-22 | — | — | EP | disclosed |
| CN-1208314-C | Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use | AVENTIS PHARMA GMBH (DE) | 2005-06-29 | — | — | CN | disclosed |
| US-6743790-B2 | A UREA OR THIOUREA DERIVATIVES CONTAINING AMIDE GROUP USEFUL AS ANTICOAGULANTS AND ANTIINFLAMMATORY AGENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-06-01 | — | — | US | disclosed |
| CN-1427818-A | Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use | AVENTIS PHARMA GMBH (DE) | 2003-07-02 | — | — | CN | disclosed |
| EP-1299354-A2 | FACTOR VIIA INHIBITORY (THIO)UREA DERIVATIVES, THEIR PREPARATION AND THEIR USE | Aventis Pharma Deutschland GmbH (DE) | 2003-04-09 | — | — | EP | disclosed |
| WO-2001094301-A2 | FACTOR VIIA INHIBITORY (THIO)UREA DERIVATIVES, THEIR PREPARATION AND THEIR USE | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-12-13 | — | — | WO | disclosed |